Helicos Biosciences: modeFinance Credir Report

If you want to know more, ASKMORE TM

modeFinance’s credit report.

Almost every day millions of peoplearound the world are wondering the realcreditworthiness of the companies withwhich they are in business. Every daythese questions remain unanswered.modeFinance

TM

now aims to answer thesequestions in a simple, complete andimmediate way.

ASKMORETM

is the modeFinanceTM

product which gives the chance toevaluate the credit risk for every companyfrom all around the world.

ASKMORETM plans 3 types of reports:

s-peek Basic Plus

ASKMORETM

Basic:This report includes modeFinance TM

’ sMORE Credit Ratings and MORE CreditLimit to help you in the decision making.It covers all essential information includingfinancial statements of the last three yearsand descriptive information including tradedescription and sector analysis.This report type is ideally suited fordecisions on transactions with each levelof credit risk.

modeFinanceTM HeadquarterBuilding A - AREA Science ParkPadriciano 99 - 34149 Trieste - ItalyPh.: +39 040 375 5337Fax: +39 040 375 [email protected]

askMORETM is a registered mark of modeFinanceTM

HELICOS BIOSCIENCES CORP.Wednesday, 21 November 2012

MORE Credit Rating

key

D C CC CCC B BB BBB A AA AAA

MORE Credit Rating

key

D C CC CCC B BB BBB A AA AAAnot

available

non return extremlypathological

pathological highdanger

weak sufficient adequate good very

strongextremely

strong

Company name HELICOS BIOSCIENCES CORP.

Identification number US050587367

Country United States of America

ZIP code and city 02139 - CAMBRIDGE

Address BUILDING 700

+1 617 264 1800

www.helicosbio.com

[email protected]

Legal form Not available

Account Consolidated

Incorporation date 2003/05

NACE 2 Sector 2660 - Manufacture of irradiation, electromedical and electrotherapeutic

equipment

Listed

Status Active

MORE Credit limit Not assessable on the base of the available informations

31/12/2011 31/12/2010 31/12/2009

Turnover (th e) 2,496 3,289 2,101

Rating C C CCC

Probability of default 57.00% 57.00% 16.00%

Confidence Level 100% 100% 100%

Solvency ratios

Leverage ratio -1.23 -2.14 3.67

Total asset/Total liabilities 0.19 0.53 1.27

Liquidity ratios

Current Ratio 0.18 0.55 1.87

Quick Ratio 0.11 0.31 1.35

Profitability and economic equili-

brium ratios

Return on investement ROI (%) -200.61 -259.24 -101.44

Return on equity ROE (%) -53.25 -304.38 -491.74

Asset turnover 1.26 0.63 0.11

Interest paid weight -0.13 -0.03 -0.04

Gross Profit/Operating revenue 0.93 1.07 1.35

Interest Coverage ratios

EBIT interest coverage ratio -8.89 -35.92 -27.72

Analysis and trend of financial

strength


MORE Credit Rating

key


modeFinance TM srlVAT number [email protected]

Area Science Park,Padriciano 99. 34149 Trieste, ItalyTel. +39 040 3755337Fax +39 040 3756741

Sector Analysis

Company Healthy Balanced Vulnerable Risky

Solvency ratios

Leverage ratio -1.23 0.46 1.40 1.70 -1.30

Total asset/Total liabilities 0.19 3.04 1.69 1.42 0.97

Liquidity ratios

Current Ratio 0.18 2.69 1.56 1.23 0.75

Quick Ratio 0.11 2.04 1.15 0.89 0.45

Profitability and economic equilibrium ratios

Return on investement ROI (%) -200.61 11.61 4.97 -2.48 -11.30

Return on equity ROE (%) -53.25 13.12 7.00 -11.50 -113.70

Asset turnover 1.26 1.07 1.09 0.97 1.14

Interest paid weight -0.13 0.01 0.14 -0.03 -0.21

Gross Profit/Operating revenue 0.93 0.35 0.21 0.15 0.13

Interest Coverage ratios

EBIT interest coverage ratio -8.89 79.81 4.58 -2.04 -3.98

Cash Conversion Cycle (days)

Days Sales Of Inventory (DIO) 103 46 45 47 50

Days Sales Outstanding (DSO) 47 66 69 66 47

Days Payable Outstanding (DPO) 91 29 39 43 43

Cash Conversion Cycle (DIO + DSO - DPO) 59 83 78 75 61

Numer of analyzed companies - 975 1,737 706 136

(Average) Rating C A BBB B CC

The sector has been chosen according to:

international companies in the sector NACE 2 26 with financial data of year 2011.


MORE Credit Rating

key




Sector Analysis - Graphs


MORE Credit Rating

key




Balance Sheet

BALANCE SHEET (th e) 31/12/2011 31/12/2010 31/12/2009

Accounting practice Local GAAP Local GAAP Local GAAP

Exchange rate USD - EUR 0.77286 0.748 0.69416

Number of months 12 12 12

Total assets 1,982 5,238 18,419

Fixed assets 84 208 1,395

Intangible fixed assets 0 0 0

Tangible fixed assets 39 94 1,184

Other fixed assets 45 114 211

Current assets 1,897 5,030 17,024

Stocks 703 2,195 4,739

Debtors 323 726 933

Other current assets 871 2,109 11,352

Cash & cash equivalent 772 1,880 11,058

Shareholders funds -8,454 -4,612 3,947

Capital 67 65 55

Other shareholders funds -8,522 -4,677 3,892

Total liabilities 10,436 9,850 14,472

Non current liabilities 19 669 5,369

Long term debt 0 504 1,445

Other non-current liabilities 19 165 3,924

Current liabilities 10,417 9,182 9,104

Loans 2,431 2,079 1,925

Creditors 619 594 698

Other current liabilities 7,367 6,509 6,481

Total shareh. funds & liab. 1,982 5,238 18,419

NET DEBT (th e) 31/12/2011 31/12/2010 31/12/2009

Short term debts 2,431 2,079 1,925

Long term debt 0 504 1,445

Cash & cash equivalent 772 1,880 11,058

Net debt 1,659 703 -7,688

31/12/2011 31/12/2010 31/12/2009

Working capital 407 2,328 4,974

Net Current Assets -8,519 -4,151 7,920

31/12/2011 31/12/2010 31/12/2009

Days Sales Of Inventory (DIO) 103 244 823

Days Sales Outstanding (DSO) 47 81 162

Days Payable Outstanding (DPO) 91 66 121

Cash Conversion Cycle (DIO + DSO - DPO) 59 259 864


MORE Credit Rating

key




Income Statement

INCOME STATEMENT (th e) 31/12/2011 31/12/2010 31/12/2009

Accounting practice Local GAAP Local GAAP Local GAAP

Exchange rate USD - EUR 0.77286 0.748 0.69416

Number of months 12 12 12

Sales 2,496 3,289 2,101

Revenues growth (%) -24 57 -

Other revenues +/- variation in inventories and contract in progress + Fixed assets

own construction capitalized0 0 0

Operating revenue / turnover 2,496 3,289 2,101

Total operating costs 7,171 19,776 22,196

Costs growth (%) -64 -11 -

Service costs - - -

Material costs - - -

Costs of employees - - -

EBITDA -4,667 -14,308 -18,494

Depreciation 8 2,179 1,602

EBIT -4,674 -16,487 -20,096

Financial P/L 172 2,449 687

Financial revenue 0 14 52

Financial expenses -172 -2,435 -635

Interest paid 526 459 725

P/L before tax -4,502 -14,038 -19,409

Extr. and other P/L 0 0 0

Extr. and other revenue - - -

Extr. and other expenses - - -

P/L before tax + Extr. and other P/L -4,502 -14,038 -19,409

Taxation 0 0 0

P/L for period -4,502 -14,038 -19,409

31/12/2011 31/12/2010 31/12/2009

Costs of Good Sold 165 -229 -742

Gross Profit 2,331 3,518 2,843

Other Operating Expenses 7,005 20,005 22,938

31/12/2011 31/12/2010 31/12/2009

Cash flow -4,494 -11,860 -17,806

Added value - - -

31/12/2011 31/12/2010 31/12/2009

Number of employees 10 22 80


MORE Credit Rating

key




Evolutions and trends


MORE Credit Rating

key




Qualitative information

Full overview The company, headquartered in Cambridge, Massachusetts, is engaged in the development of genetic analysis

technologies for the research, drug discovery, and clinical diagnostics markets. The technology platform is designed

to sequence individual DNA or RNA molecules with unprecedented throughput, at dramatically lower costs than

any other method. The company was co - founded in 2003 by Steve Quake, a professor of Bioengineering and

Applied Physics at Stanford University, Eric Lander, director of the Broad Institute of MIT and Harvard University,

Noubar Afeyan, managing partner of Flagship Ventures, and Stanley Lapidus, an experienced entrepreneur in

the life sciences industry. The company began operations in February 2004, with backing from a leading group

of investors, including Atlas Venture, Flagship Ventures, Highland Capital Partners, MPM Capital and Versant

Ventures. It initially focused its efforts in research and development activities that proved the technical feasibility

of the tSMS approach. In January 2006, the company began commercial operations, announcing its Early - Access

Collaboration Program where thought leaders in the genomics field are given access to the technology to help

develop specific applications. Dr. Leroy Hood and the Institute for Systems Biology in Seattle, WA, is the first

program partner.

History Co - founded by Steve Quake, a professor of Bioengineering and Applied Physics at Stanford University, Eric

Lander, director of the Broad Institute of MIT and Harvard University, Noubar Afeyan, managing partner of Flagship

Ventures, and Stanley Lapidus, an experienced entrepreneur in the life sciences industry.

Primary business line Engaged in the development of genetic analysis technologies for the research, drug discovery, and clinical

diagnostics markets.

Secondary business line Not available.

Main activity Manufacturing.

Secondary activity Not available.

Main products and services Genetic analysis technologies for the research, drug discovery, and clinical diagnostics markets.

Size estimate Not available.

Strategy, organization and policy Not available.

Strategic alliances Not available.

Membership of a network Not available.

Main brand names Not available.

Main domestic country United States of America.

Main foreign countries or regions Not available.

Main production sites Not available.

Main distribution sites Not available.

Main sales representation sites Not available.


MORE Credit Rating

key




Main customers Not available.

Auditor/Advisor/Bank

name type address

PRICEWATERHOUSECOOPERS LLP Auditor -

Computershare Shareholder Services Transfer Agent -

Board

name date of birth nationality function

Mr. Bruce C Ginsberg - - Director

Mr. Ronald A Lowy - - Director

Sharehoders (the first twenty shareholders ordered by Direct %)

DIMENSIONAL FUND ADVISORS LP via its funds Rating: A

Country ISO code US Operating Revenue (MIL $) 36.72

NACE Rev. 2, Core code - Total Assets (MIL $) 2186.66

Direct % - Number of Employees 260

Total % 0.14 Information date 2012/04

Address : Not available

ATLAS VENTURE UK LIMITED Rating: AA

Country ISO code GB Operating Revenue (MIL $) 18

NACE Rev. 2, Core code - Total Assets (MIL $) 3.72


Total % - Information date 2009/07



MORE Credit Rating

key




FLAGSHIP VENTURES INC Rating:


NACE Rev. 2, Core code - Total Assets (MIL $) -




VERSANT VENTURE CAPITAL I LP Rating:

Country ISO code US Operating Revenue (MIL $) -





VERSANT VENTURES Rating:






Subsidiaries (the first twenty subsidiaries ordered by Direct %)

HELICOS BIOSCIENCES SECURITIES CORPORATION Rating:

Country ISO code US Operating Revenue (MIL $) -


Direct % WO Number of Employees -



MORE Credit Rating

key




ASKMORE rating guide

General vision A credit rating is an opinion of the general creditworthiness of an obligor (issuer rating), or the creditworthiness of

an obligor in respect of a specific debt security, or other financial obligation (issue rating), based on relevant risk

factors.

The Multi Objective Rating Evaluation (MORE) model is essentially used to assess the level of distress of industrial

companies by using data included in financial statements.

The basic idea of the model is to analyze a set of financial and economic ratios in a predictive corporate bankruptcy

model with the purpose of creating a fundamental credit rating model for each industrial sector. Results of the

model are obtained by applying newly developed numerical methodologies, drawing together financial theory,

data mining and engineering design methodologies. The heart of MORE is a multi dimensional and multi objective

algorithm that produces a classification of each company, by taking into account any attributes (such as sector and

country) characterizing a firm.

The model gives the opportunity to assign a rating to a company even without considering a complete data analysis

and allows to process quality information. It induces a better understanding of a company’s strength and weakness

thanks to sophisticated data mining tools and taking into account the analyst knowledge.

The MORE rating vision is to look at the fundamental economics of the company. The main idea is to evaluate the

rating observing every aspect of the economical and financial behavior of the company: better is the equilibrium

between the different aspects, better will be the final rating.

This is done studying, evaluating and aggregating the most important sections of the financial and economic

behavior of a company such as: profitability, liquidity, solvency, interest coverage and efficiency.


MORE Credit Rating

key




Rating scale

Rating class Rating macro class Assessment

AAA

Healthy

The company’s capacity to meet its financial commitments is extremely strong. The company shows an excellent

economic and financial flow and fund equilibrium.

AAThe company has very strong creditworthiness. It also has a good capital structure and economic and financial

equilibrium. Difference from AAA is slight.

AThe company has a high solvency. The company is however more susceptible to the adverse effects of changes in

circumstances and economic conditions than companies in higher rated categories.

BBB

Balanced

Capital structure and economic equilibrium are considered adequate. The company’s capacity to meet its financial

commitments could be affected by serious unfavourable events.

BBA company rated BB is more vulnerable than companies rated BBB. Furthermore the company faces major ongoing

uncertainties or exposure to adverse business, financial, or economic conditions.

B

Vulnerable

The company presents vulnerable signals with regards to its fundamentals. Adverse business, financial, or economic

conditions will be likely to impair the company’s capacity or willingness to meet its financial commitments.

CCC

A company rated CCC has a dangerous disequilibrium on the capital structure and on its economic and financial

fundamentals. Adverse market events and an inadequate management could affect with high probability the

company’s solvency.

CC

Risky

The company shows signals of high vulnerability. In the event of adverse market and economic conditions, the

company’s strong disequilibrium could increase.

CThe company shows considerable pathological situations. The company’s capacity to meet its financial

commitments is very low.

D The company has not any longer the capacity to meet its financial commitments.


MORE Credit Rating

key




Fundamental Credit Rating Ratios

Analysis area Ratio Assessment

Solvency ratios

Leverage ratioThis measures the level of total liabilities of the company in comparison

with equity.

Assets to debtThis indicates company’s solvency. The company shows a level of deficit

when the value of this ratio is under one unit.

Financial ratios Fixed Assets coverage ratioThis is calculated only for holdings. It measures the capital structure i.e.

whether a company covers the fixed assets with long term capital.

Liquidity ratios

Current ratioThis measures whether a company has sufficient short-term assets to cover

its short-term liabilities.

Quick ratioThis compares current liabilities only to those assets that can be readily

turned into cash.

Profitability and economic ratios

Return on Investement(ROI)This measures the profitability of company investments without regard to

the way the investment is financed.

Return on Equity(ROE) This measures the profitability of the equity.

Asset turnover

This indicates the investments turnover with regards to sales. The level

assumed from the ratio depends on the sector in which the company

operates.

Profit margin This indicates the profitability of sales.

Interest coverage ratio Interest Paid coverage

This indicate the ability of the company to cover interest expenses through

the economic margins (Gross profit and EBIT) and through the cash flow

from operating activities.


MORE Credit Rating

key




MORE Credit Limit, Probability of default and Confidence Level

MORE Credit Limit MORE Credit limit is the estimation of the amount of maximum credit that is possible to assign on a commercial

relationship with the analyzed company with an outlook of one year.

modeFinance used the following values associated with the company analyzed while computing the credit limit:

• Size;

• Years in Business;

• Average number of suppliers;

• Liquidity of the company and the comparison with its sector;

• The funds dedicated to be paid to suppliers;

• The likelihood that a company may pay its debts in the next 12 months (MORE Ratings).

The credit limit in this report is merely a suggested value of commercial credit limit calculated on the basis of annual

public data. This value should be reviewed by paying attention to the Confidence Level value and by using other

information such as other business information, news... etc; and private information such as the relationship with

client, history of payments, guarantees and the knowledge of the sector.

Probability of default e Confidence

Level

In addition to the MORE Rating, modeFinance also estimates the probability of default and provides a level of

confidence. The probability of default is the degree of certainty (in quantitative terms) that the company will go

into default.

As the probability of default is strongly affected by the economic climate that the company is operating in,

companies in the same MORE class will not necessarily have the same probability of default.

The MORE model can produce a MORE rating even if there is missing data by using an associated confidence level:

Confidence =

∑Available Information∑

Total Information

The level of confidence does not indicate financial confidence in the company. It is a reflection of the variations in

availability of financial data across Europe due to filing regulations and suggests the degree of financial detail the

MORE rating is able to take into account for each company.

For companies with fully populated records a confidence level of 100% would be applied: companies where no

financial data is provided, 0%. This puts the MORE rating in a context for the user and aids interpretation.


MORE Credit Rating

key




Notes and disclaimer

NOTES modeFinance has based the present analysis on the company available financial statements, coming from one or

more of the following sources: local providers, Commercial Register (Companies House), websites, modeFinance’s

database etc.

DISCLAIMER All Rights Reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any

form by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior permission of

the publisher modeFinance. The facts of this report are believed to be correct at the time of publication but cannot

be guaranteed. Please note that the findings, conclusions and recommendations that modeFinance delivers will

be based on information gathered in good faith from both primary and secondary sources, whose accuracy we

are not always in a position to guarantee. As such modeFinance can accept no liability whatever for actions taken

based on any information that may subsequently prove to be incorrect.

Contacts

Company modeFinance

Products MORE rating

Where AREA Science Park

34149 Trieste, via Padriciano 99 - ITALY

Info [email protected]

web www.modefinance.com

Phone +39 040 3755337

Date post:	09-Mar-2016
Category:	Documents
Upload:	modefinance
View:	222 times
Download:	4 times

Helicos Biosciences: modeFinance Credir Report

Documents